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Abstract
Background and aims: The prevalence of asthma has been keeping arising with unknown
etiology. The cumulative evidence indicates that chronic rhinosinusitis (CRS) closely relates to
asthma, but the detailed mechanisms remain unclear. The present study aimed to take insight into
the role of Staphylococcus enterotoxin B (SEB) in a possible association between CRS and asthma.
Methods: 38 patients with both CRS and asthma underwent functional endoscopic sinus surgery.
Serum specific IgE and cytokines, clinical symptoms of CRS and asthma were evaluated before and
after the surgery. Peripheral blood mononuclear cells (PBMCs) were separated from the patients
and cultured. Th2 response of the cultured PBMCs in the presence or absence of specific antigens
and SEB was evaluated.
Results: Besides the improvement of CRS symptoms, amelioration of asthma was also observed
in the patients with both CRS and asthma after the sinus surgery. The preoperatively elevated Th2
cytokines, IL-4 and IL-5, normalized postoperatively. Th2 response was generated with separated
PBMCs in the presence of specific antigens. SEB was required for maintaining Th2 response in these
separated PBMCs.
Conclusion: The present results indicate that a possible link exists between CRS and lower airway
hypersensitivity. Sinusitis derived SEB may play a role in sustaining Th2 responses in the low airway
hypersensitivity related to sinusitis.
Background
Asthma is a chronic respiratory disease characterized by
episodes or attacks of inflammation and narrowing of
small airways in response to exposure to environmental
stimuli [1]. Asthma attacks can vary from mild to life-
threatening. Asthma has been a significant health prob-
lem in the world, with an ever-increasing morbidity and
mortality, and economic impact through both direct and
indirect costs over the last 20 years [2]. Although the
research in asthma has advanced rapidly in recent years,
the etiology of asthma remains unclear.
The cummulative evidence suggests that CD4+ T-helper
(Th)2 lymphocytes play a crucial role in the pathogenesis
of asthma. Th-2 inflammatory response has been docu-
mented to predominate over Th1 response in the patients
with asthma. Significant correlation has been identified
between high levels of interleukin (IL)-4 and IL-5 and
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clinical severity of asthma [3,4]. The role of Th2 cytokines
is of importance because IL-4 and IL-13 can promote IgE
production [5]. Antigen specific IgE is a key molecule in
mediating antigen-related asthma [6]. However, how the
established Th1/Th2 balance breaks down, how the
skewed Th2 polarization last for a long time in asthma
patients remains to be understood.
A close relationship between chronic rhinosinusitis (CRS)
and asthma has been noticed for decades [7,8]. In clinical
practice, we have noticed that many patients who suffer
from asthma or allergic rhinitis report the pre-existed CRS.
The clinical data have demonstrated that surgical and
non-surgical CRS management can improve clinical
symptoms of CRS and asthma [9-11]. These data impli-
cate that substance derived from the sinus infection may
play a role in the pathogenesis of asthma with unknown
mechanism.
Although the causes of CRS are complicated, it is accepted
that bacterial infection is one of the causes in most cir-
cumstances. Staphylococcus aureus (S. aureus) is a common
pathogen contributing to both acute and chronic rhinosi-
nusitis [12]. It produces exotoxins such as Staphylococcal
enterotoxin B (SEB), SEA and toxic shock syndrome toxin-
1 (TSST-1), which possess potent immune activity to
affect immune system. Reports demonstrate high levels of
SEB and SEA in nasal secretions of patients with CRS and
asthma [13]. The exotoxins have the potential in regulat-
ing airway immune reactions during CRS by contaminat-
ing airway mucosa through secretions from the sinus ostia
[14]. SEB is capable of increasing airway epithelial barrier
permeability, facilitating macromolecular protein antigen
crossing of the epithelium to contact immune cells in sub-
epithelial region [15].
SEB induces vigorous activation, proliferation, and
cytokine production by T cells that express the specific
TCR variable beta (Vβ) chains. Some investigators associ-
ate SEB with inducing the Th1 pattern inflammation [16-
18], however, the accumulative evidence indicates that
SEB is also involved in the pathogenesis of allergic dis-
eases [19-22]. We and others have shown that the simul-
taneous exposure to SEB and food antigens enhances
susceptibility to allergic reactions [14,23]. SEB triggers
immune cells to release Th2 cytokines IL-4, IL-5 and IL-13
[14,24-26] and enhances antigen-specific immune
responses [19,27]. Comparing atopy patients with healthy
subjects, in the culture supernatants of PBMC with SEB
stimulation, atopy patients produced more Th2 cytokines,
such as IL-4 and IL-5, and less Th1 cytokines, such as inter-
feron (IFN)-γ [28].
Our previous study [23] and others [29] show that the
CRS can be an intrinsic source of SEB in the body. The rhi-
nosinuses may be frequently contaminated and colonized
by the S. aureus [12]. CRS derived SEB can be discharged
with secretions to the nasal cavity and then be compelled
backward to be swallowed down the gastrointestinal tract
or to contaminate the airway mucosa.
Therefore, we hypothesized that CRS derived SEB might
be a factor in the induction and maintenance of low air-
way hypersensitivity. In the present study, with a group
patient suffering from both CRS and allergic asthma, their
CRS was treated with functional sinus endoscopic surgery
(FESS), we aimed to observe: (i) amelioration of clinical
symptom of asthma; (ii) regulation of Th2 response and
(iii) the role of SEB in the maintenance of the skewed Th2
polarization in separated PBMCs.
Methods
Subjects
This study was carried out at the Institute of Allergy and
the Department of Otolaryngology of Shanxi Medical
University. The study was approved by the local Ethical
Committee. A written consent was obtained from each
subject. Patients with both CRS and asthma were consid-
ered to be enrolled into this study. CRS diagnosis: at least
a one-year history of clinical symptoms including puru-
lent nasal secretions, postnasal secretions and middle
meatus purulent secretions. Computed tomography (CT)
scans showed evidence of maxillary sinusitis or/and eth-
moid sinusitis. No underlying immunodeficiencies, cystic
fibrosis, bronchiectasis, chronic obstructive pulmonary
disease, diabetes mellitus, neoplasia, or fungal rhinosi-
nusitis. Thirty-eight patients with both CRS and chronic
asthma (21 females and 17 males, ranging from 16 to 48
years with a mean age of 28.5 years) were enrolled to this
study. A group of 25 patients with CRS alone (male = 14;
age = 26.8 ± 7.8) were enrolled into this study served as
controls. All patients required surgical treatment since
they had tried different medical remedies and had not
obtained satisfactory results. Routine physical examina-
tions were performed on each patient upon admittance.
These 38 patients also suffered from perennial asthma. All
of them clearly stated that asthma symptoms occurred
after the occurrence of sinusitis. The diagnosis of asthma
was based on the reported guidelines [30]. The history of
asthmatic symptoms included episodic dyspnea and
wheezing. These symptoms could be controlled by inhal-
ing β2-adrenoreceptor agonists, or theophyline prepara-
tions. Lung function tests were performed for patients
with asthma before and 2 months after sinus surgery. A
group of 23 patients with asthma alone (male = 12; age =
31.3 ± 8.3) were enrolled into this study served as asthma
controls. Subjects were nonsmokers and not have used
any inhaled corticosteroids for at least 2 months, or long-Clinical and Molecular Allergy 2006, 4:7 http://www.clinicalmolecularallergy.com/content/4/1/7
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acting β2-agonists for at least 48 hours before antigen
screening.
Twenty healthy subjects were enrolled into this study
served as healthy controls (male = 10; age = 20.8 ± 0.5).
Skin prick test
One drop of extract of each airborne antigen (1 mg/ml,
purchased from Beijing Xiehe Hospital, Beijing, China)
was applied to the patients' forearm. The skin covered by
the drop of antigen was pricked with 1 mm single-peak
lancets. The positive control was performed using 10 mg/
mL histamine dihydrochloride; the negative control using
saline solution. The results were read after 15 min. The
outline of each weal was documented using a piece of
transparent paper to copy the wheal [31]. The skin wheal
areas were determined with scanned digital files using
software ImageJ. Skin prick tests were regarded positive
when the area was larger than 7 mm2.
Inhaled allergen challenge
In order to determine the airway response to specific anti-
gens, we chose the antigens to which the subject had had
the largest wheal area on skin prick testing. At baseline,
subjects underwent an inhaled incremental allergen chal-
lenge. Concentrations of 200 to 30,000 SQU/ml antigen
extract (Beijing Xiehe Hospital, Beijing, China) were pre-
pared in 0.9% saline. Baseline forced expiratory volume
(FEV)1 was determined after inhalation of 0.9% saline,
and then start from the lowest dose, the subject inhaled
incremental concentrations of allergen. All inhalations
were delivered through a breath-driven dosimeter by
inspiring slowly from functional residual capacity to total
lung capacity over 1 second and then holding breath for 6
seconds while wearing a nose clip. Five breaths were
inhaled for each concentration. Inhalation of increasing
concentrations of allergen continued until an early asth-
matic response (EAR) (a decrease of >20% of saline base-
line value) was achieved. FEV1 was then measured at the
following times after allergen inhalation: 20, 40 and 60
minutes and 3, 5 and 8 hours. The later asthmatic
response (LAR) was defined as a decrease in FEV1 from
saline baseline value of more than 15% between 3 and 7
hours after allergen challenge.
Serology
Blood samples were collected from each subject at admit-
tance and two months after the FESS. The sera were sepa-
rated and stored at -70°C until use. Levels of IL-4, IL-5,
INF-γ, total immunoglobulin (Ig)E and specific IgE were
determined by Enzyme-Linked Immunosorbent Assay
(ELISA) (Genetimes Tech Inc. Shanghai, China).
Scores of clinical symptoms
The clinical symptoms of both CRS and asthma were
scored on a four-point scale: 0 for no symptoms, 1 for
mild, 2 for moderate and 3 for severe. Symptoms of
sinusitis included stuffed nose, nasal purulent discharge
and sinusitis-caused headache. Symptoms of asthma
included frequency of attack, wheezing and shortness of
breath. An overall score of the symptoms was determined
by the patients and their physicians before and after sur-
gery as well as the follow-up visits.
Treatment of CRS
All patients in this group were treated with FESS. The pro-
cedures of this surgery were referred to Kennedy's report
[32,33]. The patients were asked to follow up in the clinic
0.5, 1, 2, 6 and 12 months after the surgical procedure.
Necessary treatments were done in the follow-up visits or
upon re-admitted into the hospital if required.
Evaluation of SEB in sinus (or nasal) wash fluids (SWF)
Every patient with CRS underwent maxillary sinus punc-
turing and irrigating with saline. The SWF was collected
prior to other procedures. 5 ml saline was injected into the
sinus cavity and recollected and stored at -70°C until use.
Protein content in SWF was evaluated with UV spectro-
photometer (Beckman DU-65) at 280 nm. Contents of
SEB, SEA and TSST1 (toxic shock syndrome toxin 1) in
SWF were evaluated with ELISA (Biochem 21, Inc. Shang-
hai, China). Nasal lavage fluids (5 ml saline) instead of
sinus irrigation were collected from the healthy controls
and asthma controls. None of the subjects had acute
upper respiratory acute infections within the past month.
Identification of S. aureus in the sinuses
Surgically removed sinus tissues were obtained from each
patient (a nasal lateral wall swab was obtained from
asthma alone patients and healthy controls instead) and
were sent to the Microbiological Laboratory within 30
minutes. The procedures were referred to out previous
report [23].
Antigen specific CD4+ cell proliferation assay
PBMC preparation
PBMCs were isolated from heparinized blood samples by
density gradient centrifugation over Ficoll-Paque (Bio-
chem 21, Inc. Shanghai, China). Cells were washed twice
and resuspended in complete RPMI 1640 medium (Bio-
chem 21, Inc. Shanghai, China), which was supplemented
with L-glutamine, 10% fatal calf serum, 200 U penicillin/
mL, 200 µg streptomycin solution/mL.
Allergen-induced PBMC proliferation studies
The separated PBMCs were cultured in triplicate at 5 × 105
cells/well in 200 µL media in the presence of anti-CD3 (10
µg/ml) and anti-CD28 (2 µg/ml) for 3 days before theClinical and Molecular Allergy 2006, 4:7 http://www.clinicalmolecularallergy.com/content/4/1/7
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addition of allergen. 1 µg/ml the strongest responsive
antigen in the skin prick test (a mixture of the 15 antigens
was used for the groups of healthy and CRS) was added to
the culture. The culture continued for another 4 days. The
supernatants were collected at the end of culture. The
cytokines of Th1 (IFN-γ) and Th2 (IL-4) in the superna-
tants were determined with ELISA using commercial rea-
gent kits (Biochem 21, Inc. Shanghai, China) following
manufacturer's instruction. Another batch of the cells was
cultured in the presence of ionomycin (300 ng/ml) and
brefeldin (10 µg/ml) for internal staining in addition to
the culture conditions above. These cells were fixed with
1% paraformaldehyde for 1 h at room temperature,
stained with fluorescein isothiocyanate (FITC) labeled
anti-IL-4 antibody (for Th2 cells) and phycoerythrin (PE)
labeled anti-IFN-γ antibody (for Th1) for 30 min on ice.
The positively stained cells were counted with flow cytom-
etry. 20,000 events were analysed for each sample. Nega-
tive control staining was omit primary antibodies or stain
with isotype Igs.
Role of SEB in the maintenance of Th2 reactions
Another batch of the separated PBMCs from each subject
was cultured respectively in the presence of specific anti-
gens as described above. SEB (20 µg/ml) was added to the
culture on day 9 that lasted to the end of the experiments.
The supernatants were sampled on day 1 and every 2 days.
IL-4 levels in the supernatants were measured with ELISA
as described above.
Statistics
Data is expressed as means ± SD. Statistical significance
was determined using the student t tests or the χ2tests. Sig-
nificant difference was accepted when p values were less
than 0.05.
Results
Staphylococcus aureus and SEB are identified in the 
sinuses of CRS patients
The surgical removed sinus tissues were subjected to S.
aureus culture and the SWF samples were used to evaluate
levels of SEB. 94.7% (36/38) CRS-asthma and 32% (8/25)
CRS patients had S. aureus growth in the surgical removed
tissues (χ2 test: p < 0.05). CRS-asthma Patients showed
much higher levels of SEB in the SWF that decreased sig-
nificantly 2 months after FESS (Fig 1).
Clinical symptoms of patients with CRS-asthma and CRS 
alone were improved after FESS
Before the FESS, patients with CRS-asthma had a signifi-
cantly lower baseline FEV1 value (2.58 ± 0.88, p < 0.01)
compared with healthy controls (3.78 ± 0.56) and CRS
controls (3.85 ± 0.48), but had no significant difference
with asthma controls (2.61 ± 0.71). Two months after the
FESS, FEV1 value fall-percentage in response to antigen
challenge was also improved in CRS-asthma patients
(improvement >12% could be considered as positive
results), but not in patients with asthma alone (Fig 2A).
The post-FESS clinical asthma scores decreased signifi-
cantly (Fig 2B, the left penal). The clinical symptoms of
CRS, such as nasal blockage and nasal purulent secretions
were also assessed by patients. The FESS resulted in mark-
edly attenuating the CRS clinical scores (Fig 2B, right
side).
Serum IgE and Th2 cytokine levels are repressed after FESS
As shown in Fig 3, before the FESS, serum cytokine assess-
ment resulted in a Th2 skewed polarization profile and
higher specific IgE levels in CRS-asthma and asthma alone
patients. After the FESS, the levels of specific IgE, IL-4 and
IL-5 were attenuated significantly in CRS-asthma patients,
but not in asthma alone patients. There were no signifi-
cant changes between the two assessments in the control
groups.
The skin prick test reactions decrease after the FESS
Each subject underwent two times of the skin prick test
with a set of 15 common airborne antigens before and
two months after the FESS. The results showed that the
wheal area larger than 7 mm2 was observed in the CRS-
asthma patients in 1 to 6 antigens as depicted in Figure 4A
that decreased significantly two months after the FESS.
The number of the positive antigens in the CRS-asthma
group was also reduced after the FESS (Fig 4B). The wheal
area of the skin prick test of the patients with asthma
SEB was evaluated with ELISA in the sinus wash fluids Figure 1
SEB was evaluated with ELISA in the sinus wash fluids. Bars 
represent levels of SEB as mean ± SD. *, p < 0.05, compared 
with healthy controls. #, p < 0.05, compared with the second 
time within the same group. 1st: samples are collected before 
the functional endoscope sinus surgery (FESS). 2nd: samples 
are collected 2 months after the FESS. Healthy: healthy con-
trols. CRS: patients with chronic rhinosinusitis. Asthma: 
patients with asthma. CRS-asthma: patients with both CRS 
and asthma.
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alone was not significantly different from that of the CRS-
asthma patients before FESS; the results did not show
much difference between the two tests in asthma alone
patients. The healthy control group did not respond to
any tested antigens (the wheal area was less than 7 mm2),
nor in patients with CRS alone. Saline was used as the
diluent for all the antigens and was also used as the nega-
tive control. No special reactions were observed on the
saline spots in all the subjectives.
The antigen specific Th2 response is augmented by the 
exposure to SEB
As depicted in Fig 5, the results showed when the sepa-
rated PBMCs from CRS-asthma patients were stimulated
by specific antigens or SEB, the Th2 cytokine production
increased significantly; a further increase was observed
when the Th2 cells were stimulated with specific antigens
and SEB concurrently. The PBMCs from asthma alone
patients also showed an increase in Th2 profile response
similar to that from CRS-asthma patients, but the Th2 pro-
file did not further increase in the environment of
SEB+antigen. The T cells from patients with CRS alone
showed a Th1 profile with an increase in Th1 cytokine
production, but that did not further increase in response
to the stimulation of SEB or the mixed antigens or both.
The separated PBMCs from the healthy controls were also
stimulated with SEB or mixed antigens or both. The stim-
ulation did not show any effect on their Th1/Th2 cytokine
profiles.
SEB plays a role in the maintenance of Th2 response
The separated PBMCs were cultured with specific antigens
in the presence or absence of SEB. In consistent with pre-
vious reports [34], we also observed an increase in IL-4
production in the samples from CRS-asthma and asthma
alone patients on day 4. However, the IL-4 production
declined rapidly afterwards. Considering SEB might be
required in maintaining the immune activity of antigen
specific Th2 cells, SEB was added to the culture. IL-4 pro-
duction increased sharply in the cells from CRS-asthma
patients, but not in the cells from asthma alone patients,
or healthy controls and CRS alone patients (Fig 6).
Discussion
The main findings of the present study include: (i) the
remove of pathogen from the rhinosinuses improved clin-
ical symptoms of patients with both CRS and asthma; (ii)
SEB plays a role in the maintenance of the skewed Th2
polarization. The improvement of asthmatic symptoms
and pulmonary function after FESS in patients with both
CRS and asthma has been reported. The present data are
compatible with previous reports. McFadden [35]
observed a group patient with sinusitis and asthma under-
going sinus surgery and showed subjective improvement
and increased respiratory function; 68 patients (85%) had
significant improvement in their sinus symptoms and 67
(83%) had relief of their asthma. In a recent study, Tosca
demonstrated an improvement in severity of asthma and
respiratory functioning, together with reduced levels of
inflammatory cells and a change from a Th2 cytokine pro-
file to a Th1 profile [36]. Jankowski [37] reported on 30
patients and 91% showed asthma improvement. In the
present study, the results approximately close to those
reports as mentioned above, the follow-up results two
month after the sinus surgery show that in addition to the
clinical recovery of CRS, their asthma clinical symptoms
had markedly improved as reported by the patients. The
lung function test in response to antigen challenge is an
objective test that demonstrates significantly improve-
CRS and asthma clinical symptoms improved after the FESS Figure 2
CRS and asthma clinical symptoms improved after the FESS. 
A, lung function after antigen challenge was assessed by 
recording FEV1 falling rate in the period of 0~8 h. B, overall 
clinical scores reported by patients. *, p < 0.05, compared 
with the 1st scores within the same group.
0
2
4
6
Astma CRS-Asthma CRS CRS-
Asthma
1st 2nd
C
l
i
n
i
c
a
l
 
s
c
o
r
e
* * *
B
Asthma Chronic sinusitis
-30
-25
-20
-15
-10
-5
0
0 20 40 60 180 360 480
CRS-Ast1
CRS-Ast2
Ast1
Ast2
Time after challenge (min)
F
E
V
1
 
(
B
a
s
e
l
i
n
e
%
)
AClinical and Molecular Allergy 2006, 4:7 http://www.clinicalmolecularallergy.com/content/4/1/7
Page 6 of 9
(page number not for citation purposes)
ment of the lung function of the patients with CRS-
asthma after FESS (Fig 2). The results and the supporting
literature suggest that rhinosinusitis might be associated
with the pathogenesis of the low airway hypersensitivity,
at least in a part of patients with CRS-asthma. Some inves-
tigators reported different results. Uri reported that the
asthma symptoms were actually not improved although
88% patients felt better after the FESS [38].
The skin antigen tests show a significant decrease in the
wheal area and the positive antigen number 2 months
after the FESS. The results implicate a decrease in the
amount of antigen specific IgE molecules binding on the
surface of mast cells in the body. This reasoning is sup-
ported by the result of specific IgE evaluation that
decreased significantly after the FESS. Another supportive
datum is the FEV1 falling value was also improved in
patients with CRS-asthma 2 months after the FESS,
because the antigen specific IgE-bearing mast cells are the
basis in the antigen induced low airway hypersensitivity.
Similar results can be found in the reports of immuno-
therapy of asthma patients that shows markedly specific
IgE repression as well as improvement of clinical symp-
toms of asthma after specific antigen immunotherapy
[39].
We may ask a question: Why could FESS decrease the
number of positive antigen in skin prick tests? As the in
vitro study with PBMC culture shows, SEB is required in
Serum specific IgE and Th1/Th2 cytokine levels were evalu- ated with ELISA Figure 3
Serum specific IgE and Th1/Th2 cytokine levels were evalu-
ated with ELISA. The serum samples were collected before 
(1st) and 2 months (2nd) after the FESS. *, p < 0.05, compared 
with the healthy controls.
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maintaining Th2 cell activity. Th2 cytokines IL-4 and IL-
13 play a crucial role in IgE production. Theoretically, the
more IgE production, the more IgE molecules bind on the
surface of mast cells, thus the more intensive reaction of
the mast cells can be in response to specific antigen chal-
lenge, the more inflammatory mediators to be released
from the mast cells that cause more intensive reaction in
antigen skin test. When the pathogen, S. aureus, has been
removed from the sinuses, less SEB is produced. There-
fore, the extent of antigen skin test reaction can be attenu-
ated to the levels beyond the discriminative capability of
the evaluation method.
The in vitro results show a skewed Th2 polarization pro-
file in patients with CRS-asthma that is consistent with
previous reports [40]. In allergic responses, B cells are
driven to undergo an immunoglobulin isotype switch,
shifting from IgM to IgE synthesis. This process involves
the rearrangement of germline DNA in the immunoglob-
ulin heavy-chain locus and is stimulated by cytokines (IL-
4 and IL-13) and CD40 activation [41]. The decrease of
serum IgE levels can be ascribed to the inhibition of Th2
cytokines as observed in this study. The function of IL-5 is
associated with eosinophils development. The eosinophil
is the critical effector cell type in inducing asthma clinical
symptoms. Using IL-5 deficient animals can not develop
Th1/Th2 responses of the separated and cultured peripheral  blood mononuclear cells (PBMCs) in response to specific  antigen stimulation Figure 5
Th1/Th2 responses of the separated and cultured peripheral 
blood mononuclear cells (PBMCs) in response to specific 
antigen stimulation. IL-4 levels (A) represent Th2 response 
and IFN-γ levels (B) represent Th1 response. The IL-4 (C) 
and IFN-γ (D) positively stained cells were detected by 
immune staining and flow cytometry. Data are expressed as 
mean ± SD. *, p < 0.05, compared with no treatment cells.
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the asthma models [42]. Therefore, the melioration of
asthma clinical symptoms in CRS-asthma patients may be
contributed by the reduction of IL-5 production, at least in
part.
IL-4 and IL-5 are over produced by Th2 cells in allergic
individuals. We also observed high levels of Th2 cytokines
in the serum of the CRS-asthma patients. Because of IL-4
is also known to be produced by mast cells and basophils
[43], the basophil is known increasing in asthmatic indi-
viduals [44], a possibility that the measured Th2 cytokines
in the present study may also be produced by other cell
types has not been ruled out. The present data emphasize
the essential role of Th2 cell produced IL-4 and IL-5 in the
induction of asthmatic clinical symptoms in patients with
CRS-asthma. The separated PBMCs produced high levels
of IL-4 when stimulated by specific antigens. These results
strongly suggest that IL-4 is secreted by antigen-activated
Th2 cells directly. The findings in this study also confirm
that a large subset of asthmatics has reactivity to aeroaller-
gens that is mediated by IL-4-secreting cells detectable in
the circulation [45].
The antigen specific Th2 cells may be silence in out-season
when the clinical symptoms of the season-type asthma
also diminish. It is understandable that these cells lack of
the specific stimulation from antigens. However,
although the IL-4 production in the cultured PBMCs
increases in the first 4 days, it declined gradually after-
wards even though in the presence of specific antigens
(Fig 6). The increase in IL-4 production in the antigen
stimulated PBMCs is consistent with previous study [46];
the decline of IL-4 production in these antigen-activated
PBMCs has gone to the opposite way against our expecta-
tion. Considering costimulators may be required in main-
taining the activity of the antigen specific Th2 cells, we
added SEB to these PBMCs since it is a T cell activator as
reported before [47]. The IL-4 production increased again
in the PBMCs from the patients with CRS-asthma, but not
in patients with asthma alone, nor in other two control
groups. Theses results have verified our postulation that
SEB acts as a costimulator in maintaining the antigen spe-
cific Th2 cell activity at certain levels. The results support
the advocation to remove any infectious foci especially in
the airway may be a help in amelioration of asthma [9].
Conclusion
In summary, we treated a group of patients with both CRS
and Asthma with FESS. Significant amelioration of the
clinical symptoms was obtained in both CRS and asthma.
The separated PBMCs from patients with CRS and asthma
show significant increase in production of Th2 cytokines
in response to the specific antigen stimulation. SEB is
required in maintaining the antigen specific Th2 cell activ-
ity in the in vitro study.
Limitation of this study
This study has not proved that SEB is also required to
maintaining the antigen specific Th2 cell activity in vivo.
The symptoms of CRS and asthma were provided by the
patients that might be bias in the results.
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